Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Zhejiang Hisun Pharmaceutical, Hisun Accuray Therapeutics patent anticoagulants

April 12, 2022

New NFE2-related factor 2 activators described by Sanofi

April 1, 2022

Procoagulant nanoparticles as platelet surrogates for management of bleeding

March 4, 2022

China Hinye Pharmaceutical presents prodrugs of the active metabolite of clopidogrel

Feb. 28, 2022

Microlyse targets VWF and clears microvascular thrombosis

Feb. 23, 2022

New coagulation factor XIa inhibitors synthesized at Janssen Pharmaceutica

Feb. 18, 2022

HMB-001 bispecific antibody shows promise for treating Glanzmann thrombasthenia

Feb. 15, 2022

Janssen Pharmaceutica presents new factor XIa inhibitors

Feb. 14, 2022

Heterozygous variants in the CD36 gene linked to bleeding phenotypes

Feb. 8, 2022

A microbiota-macrophage-iron axis regulates hematopoietic stem cell fate decisions under stress

Feb. 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...